Functional evaluation of natural killer cell cytotoxic activity in NFKB2-mutated patients
- 1 February 2018
- journal article
- letter
- Published by Elsevier in Immunology Letters
- Vol. 194, 40-43
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like diseaseJournal of Allergy and Clinical Immunology, 2015
- Mutations in NFKB2and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficienciesBMC Medical Genetics, 2014
- Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100Blood, 2014
- Combined Immune Deficiency in a Patient with a Novel NFKB2 MutationJournal of Clinical Immunology, 2014
- Novel NFKB2 Mutation in Early-Onset CVIDJournal of Clinical Immunology, 2014
- Germline Mutations in NFKB2 Implicate the Noncanonical NF-κB Pathway in the Pathogenesis of Common Variable ImmunodeficiencyThe American Journal of Human Genetics, 2013